Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1989
Effects of etybenzatropine and diazepam on levodopa-induced diphasic dyskinesias in Parkinson's diseaseE Pourcher, A M Bonnet, J Kefalos, et al.
Revue Neurologique|January 1, 1985
[The L-dopa test in Parkinson's disease]M Esteguy, A M Bonnet, J Kefalos, et al.
Neurology|October 1, 1995
Levodopa-induced dyskinesias are improved by fluoxetineF Durif, M Vidailhet, A M Bonnet, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 1, 1995
A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists: application to pergolide and bromocriptineA M Bonnet, I Serre, R Marconi, et al.
Lancet (London, England)|March 17, 1979
Bromocriptine associated with a peripheral dopamine blocking agent in treatment of Parkinson's diseaseY Agid, P Pollak, A M Bonnet, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1995
"Pure" striatonigral degeneration and Parkinson's disease: a comparative clinical studyN Gouider-Khouja, M Vidailhet, A M Bonnet, et al.
Neurology|September 1, 1994
Do parkinsonian symptoms and levodopa-induced dyskinesias start in the foot?M Vidailhet, A M Bonnet, R Marconi, et al.
Neurology|September 1, 1987
Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions?A M Bonnet, Y Loria, M H Saint-Hilaire, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1987
Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systemsM Ruberg, A Villageois, A M Bonnet, et al.
Pageof 7